Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study will assess effect of tomato oil on precancerous prostate changes

09.11.2004


Lycopene, an antioxidant commonly found in tomatoes and tomato-based products, is commonly perceived to reduce the risk of developing prostate cancer.



A new study at Northwestern University seeks to determine whether natural tomato oil with a high concentration of lycopene may reverse or delay progression of high-grade prostatic intraepithelial neoplasia (HGPIN), a condition in which abnormal cells form within the prostate and which is the strongest risk factor yet identified for the development of prostate cancer.

The study is headed by Peter Gann, M.D., professor of preventive medicine at the Northwestern University Feinberg School of Medicine and a member of the cancer epidemiology and prevention program at The Robert H. Lurie Comprehensive Cancer Center of Northwestern University.


Lycopene has been found to have anti-tumor activity in a number of laboratory studies. Also, it has been used in a number of cancer studies in humans (e.g., lung, stomach and prostate cancers) that demonstrated a lower cancer rate in people with a high dietary intake of lycopene.

Research has shown an over 20 percent reduced risk for developing prostate cancer in men who ate more cooked tomato products, such as tomato sauce. Additional studies showed that cooking tomatoes and eating them with oil substantially increases the bioavailability of lycopene.

The National Cancer Institute-sponsored study at Northwestern will use tomato extract (literally, tomato oil) from non-genetically modified tomatoes raised in Israel and specially grown to be high in lycopene content.

Results of the study will be useful for clarifying the mechanisms of action of lycopene in the prostate, for designing phase III clinical studies and, more generally, for determining the chemopreventive potential of this relatively non-toxic dietary compound. Prostate cancer is the most commonly diagnosed cancer among men in the United States, amounting to an expected 230,100 new cases and 29,900 deaths in 2004, according to the American Cancer Society.

"Prostate cancer is a rational target for chemoprevention because of its high public health burden and relatively slow growth rate," Gann said. "Although early surgical treatment of prostate cancer might be effective, it involves substantial discomfort. This, plus the wide variability in the biological behavior of prostate cancer, makes overtreatment a persistent and serious concern," Gann said.

To qualify for the lycopene HGPIN study, participants must be men age 40 and older; have had a biopsy indicating HGPIN without cancer within the last two years; be ambulatory, capable of self-care and able to perform light or sedentary work; be willing to limit intake of lycopene-containing foods, as well as supplements containing lycopene during the study period; have no prior cancer (except basal cell or squamous cell skin cancer) or complete remission for at least five years.

Elizabeth Crown | EurekAlert!
Further information:
http://www.northwestern.edu

More articles from Studies and Analyses:

nachricht Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT

nachricht Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>